Quest Diagnostics buys Bert Vogelstein’s Haystack Oncology, just six months after Series A
Quest Diagnostics is buying cancer detection startup Haystack Oncology for $300 million in cash, with plans to launch a new cancer lab test in 2024 …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.